Breaking News Instant updates and real-time market news.

XYL

Xylem

$68.55

0.485 (0.71%)

, AQUA

Evoqua Water

$20.71

(0.00%)

04:55
07/14/18
07/14
04:55
07/14/18
04:55

RBC Capital to hold a field trip

Asia Water Sector Field Trip travels throughout Singapore and Shanghai on July 9-13.

XYL

Xylem

$68.55

0.485 (0.71%)

AQUA

Evoqua Water

$20.71

(0.00%)

DHR

Danaher

$99.25

-0.4 (-0.40%)

PNR

Pentair

$43.53

0.67 (1.56%)

  • 19

    Jul

  • 25

    Jul

  • 07

    Aug

XYL Xylem
$68.55

0.485 (0.71%)

02/02/18
OPCO
02/02/18
NO CHANGE
Target $82
OPCO
Outperform
Xylem price target raised to $82 from $75 at Oppenheimer
Oppenheimer analyst Jim Giannakouros raised his price target for Xylem to $82 following the company's Q4 results. Xylem's "robust" order momentum evidences an attractive demand backdrop and mid-single-digit core growth for the "foreseeable future," Giannakouros tells investors in a research note. The analyst expects shares to sustain momentum and keeps an Outperform rating on the name.
11/27/17
STFL
11/27/17
INITIATION
STFL
Hold
Evoqua Water initiated with a Hold at Stifel
Stifel analyst Nathan Jones started Evoqua Water (AQUA) with a Hold rating and $23 price target. The analyst gives a "slight edge" to nearest peer Xylem (XYL) and believes both stocks should trade around the same valuation evel.
11/01/17
OPCO
11/01/17
NO CHANGE
Target $75
OPCO
Outperform
Xylem price target raised to $75 from $66 at Oppenheimer
Oppenheimer analyst Jim Giannakouros raised his price target for Xylem to $75 from $66 following quarterly results. The analyst reiterates an Outperform rating on the shares.
09/05/17
09/05/17
NO CHANGE

RBC Capital identifies companies that could see positive catalysts from Harvey
RBC Capital analyst Deane Dray identifies Grainger (GWW), Wesco (WCC), Xylem (XYL), and HD Supply (HDS) as companies that could benefit from Hurricane Harvey. The analyst says that Grainger " tends to be heavily involved in the cleanup and rebuilding process," and saw a one percentage point daily sales lift from Hurricane Sandy. The analyst thinks that Wesco's sales could be boosted by 0.5 percentage points as utility customers and first responders buy more of its products. She says that "Xylem's dewatering pumps business is expected to play a major role in the recovery/reconstruction efforts in flooded areas." Dray reports that the business accounts for more than 15% of the company's sales. The analyst estimates that about 11% of Hd Supply's revenue is derived from Texas.
AQUA Evoqua Water
$20.71

(0.00%)

11/30/17
JPMS
11/30/17
INITIATION
Target $23
JPMS
Neutral
Evoqua Water initiated with a Neutral at JPMorgan
JPMorgan analyst C. Stephen Tusa started Evoqua Water Technologies with a Neutral rating and $23 price target. The analyst seeks a better entry point following the post-initial public offering rally.
11/30/17
11/30/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Spirit Airlines (SAVE) was initiated with an Overweight at Stephens, while JetBlue (JBLU) initiated with an Equal Weight. 2. Consol Energy (CEIX) was initiated with a Buy at Seaport Global and Stifel. 3. Evoqua Water (AQUA) initiated with a Neutral at JPMorgan. 4. Accuray (ARAY) initiated with a Buy at Lake Street. 5. Capstone (CCT) initiated with a Buy at SunTrust. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/08/18
STFL
05/08/18
UPGRADE
STFL
Buy
Evoqua Water upgraded to Buy from Hold at Stifel
05/09/18
05/09/18
UPGRADE
Target $24

Buy
Evoqua Water upgraded to Buy after post-earnings selloff at Stifel
As previously reported, Stifel analyst Nathan Jones upgraded Evoqua Water to Buy from Hold, stating that he viewed the post-earnings selloff in the shares yesterday as overdone. He did not see anything in the report that has changed his outlook over the medium term and his 2019 EBITDA forecast is unchanged, Jones tells investors. He maintains a $24 price target on Evoqua shares.
DHR Danaher
$99.25

-0.4 (-0.40%)

02/15/18
LEHM
02/15/18
INITIATION
Target $110
LEHM
Overweight
Danaher initiated with an Overweight at Barclays
Barclays analyst Julian Mitchell started Danaher with an Overweight rating and $110 price target. The analyst initiated 24 Multi-Industry companies with a Neutral sector view.
02/01/18
ARGS
02/01/18
NO CHANGE
Target $115
ARGS
Buy
Danaher price target raised to $115 from $100 at Argus
Argus analyst John Eade raised his price target on Danaher to $115 from $100 and kept his Buy rating after a Q4 earnings beat. Eade says that based on the company's history of double-digit dividend growth, he anticipates the management to announce another increase in the payout in the coming weeks.
01/31/18
FBCO
01/31/18
NO CHANGE
Target $105
FBCO
Outperform
Danaher price target raised to $105 from $99 at Credit Suisse
Credit Suisse analyst Erin Wilson Wright raised her price target for Danaher to $105 from $99 on heightened conviction in his above-consensus 2018 EPS estimate of $4.36, reflecting continuing momentum in core revenue growth and accompanying profit margin leverage. The analyst reiterates an Outperform rating on the shares.
06/28/18
JPMS
06/28/18
DOWNGRADE
Target $105
JPMS
Underweight
JPMorgan downgrades Varian to Underweight following period of restriction
JPMorgan analyst Tycho Peterson downgraded Varian Medical Systems (VAR) to Underweight from Neutral following a period of restriction. Persistent order growth volatility, a "sluggish" end market and in the near-term and risk from the U.S.-China trade war weigh on the analyst's longer-term outlook for the stock. Varian has a dominant franchise but a mature industry and premium valuation are hard to overlook, Peterson tells investors in a research note. The analyst sees better risk/rewards in other parts of his coverage universe, including tool names Agilent (A), Danaher (DHR) and Thermo Fisher (TMO).
PNR Pentair
$43.53

0.67 (1.56%)

05/17/18
KEYB
05/17/18
DOWNGRADE
KEYB
Sector Weight
Pentair downgraded to Sector Weight from Overweight at KeyBanc
05/17/18
KEYB
05/17/18
DOWNGRADE
KEYB
Sector Weight
Pentair downgraded to Sector Weight on valuation at KeyBanc
KeyBanc analyst Jeffrey Hammond downgraded Pentair to Sector Weight from Overweight without a price target. The analyst views the valuation as full at current share levels and believes higher levels of organic growth will take time to play out. Following completion of the nVent spinout, the analyst believes Pentair offers a balanced risk/reward profile.
05/18/18
SUSQ
05/18/18
INITIATION
Target $30
SUSQ
Positive
nVent Electric initiated with a Positive at Susquehanna
Susquehanna analyst Robert Barry initiated nVent Electric (NVT) with a Positive rating following its spinoff from Pentair (PNR). The analyst said his positive thesis reflects its projected earnings growth rate and opportunities for multiple expansion as the firm executes on its financial targets, which he thinks are achievable. Barry has a $30 price target on nVent Electric shares.
05/15/18
COWN
05/15/18
UPGRADE
Target $52
COWN
Outperform
Pentair upgraded two notches to Outperform at Cowen
As previously reported, Cowen analyst Joseph Giordano upgraded Pentair to Outperform from Underperform, as he believes the company "finally" has a true identity as a pure play water equipment and technology provider. The analyst met with management, who gave a balanced approach with better comp alignment and reasonable targets that can be exceeded. He also said his proprietary pool survey implied a meaningful runway for the company's strongest business. Giordano raised his price target to $52 from $43.50 on Pentair shares.

TODAY'S FREE FLY STORIES

SBUX

Starbucks

$57.45

0.7 (1.23%)

10:55
10/16/18
10/16
10:55
10/16/18
10:55
Hot Stocks
Starbucks CEO says stock undervalued, not entering Canadian cannabis »

In an interview with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

DLTR

Dollar Tree

$81.33

0.35 (0.43%)

10:50
10/16/18
10/16
10:50
10/16/18
10:50
Options
Put spread in Dollar Tree as a defensive position is adjusted »

Put spread in Dollar Tree…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:50
10/16/18
10/16
10:50
10/16/18
10:50
General news
U.S. VIX equity volatility traded over 11% lower »

U.S. VIX equity…

NMR

Nomura

$4.83

0.02 (0.42%)

10:46
10/16/18
10/16
10:46
10/16/18
10:46
Hot Stocks
DOJ reports Nomura to pay $480M to settle RMBS claims »

The United States has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NMR

Nomura

$4.83

0.02 (0.42%)

10:45
10/16/18
10/16
10:45
10/16/18
10:45
Hot Stocks
Breaking Hot Stocks news story on Nomura »

DOJ reports Nomura to pay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:40
10/16/18
10/16
10:40
10/16/18
10:40
General news
Treasury Option Action: put positioning has resumed »

Treasury Option Action:…

FXI

iShares China Large-Cap ETF

$39.90

0.41 (1.04%)

10:40
10/16/18
10/16
10:40
10/16/18
10:40
Options
Size call spread bought in China ETF appears opening »

Size call spread bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:40
10/16/18
10/16
10:40
10/16/18
10:40
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

MS

Morgan Stanley

$45.22

1.77 (4.07%)

10:39
10/16/18
10/16
10:39
10/16/18
10:39
Upgrade
Morgan Stanley rating change  »

Oppenheimer upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

BBT

BB&T

$46.52

-0.26 (-0.56%)

10:31
10/16/18
10/16
10:31
10/16/18
10:31
Hot Stocks
BB&T to build approx. 100,000 square foot facility in Whiteville »

BB&T Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

MOMO

Momo

$37.24

-0.82 (-2.15%)

10:30
10/16/18
10/16
10:30
10/16/18
10:30
Options
Momo puts active as shares see relative weakness »

Momo puts active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$337.99

4.88 (1.47%)

10:29
10/16/18
10/16
10:29
10/16/18
10:29
Earnings
Fly Intel: What to watch in Netflix earnings report »

Netflix (NFLX) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 13

    Nov

IRBT

iRobot

$93.11

2.25 (2.48%)

10:25
10/16/18
10/16
10:25
10/16/18
10:25
Upgrade
iRobot rating change  »

iRobot upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
10/16/18
10/16
10:25
10/16/18
10:25
Conference/Events
UBS technology analyst to hold an analyst/industry conference call »

Technology Analyst…

10:25
10/16/18
10/16
10:25
10/16/18
10:25
Conference/Events
Morgan Stanley to hold an analyst/industry conference call »

Vice President Kaufman…

ABT

Abbott

$69.86

1.14 (1.66%)

, BSX

Boston Scientific

$37.64

1.21 (3.32%)

10:23
10/16/18
10/16
10:23
10/16/18
10:23
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

ABT

Abbott

$69.86

1.14 (1.66%)

BSX

Boston Scientific

$37.64

1.21 (3.32%)

SYK

Stryker

$172.45

3.03 (1.79%)

MDT

Medtronic

$95.39

1.58 (1.68%)

BAX

Baxter

$71.00

0.12 (0.17%)

EW

Edwards Lifesciences

$144.31

2.36 (1.66%)

ZBH

Zimmer Biomet

$124.31

0.72 (0.58%)

EXPE

Expedia

$120.28

1.73 (1.46%)

TRIP

TripAdvisor

$46.17

1.17 (2.60%)

BKNG

Booking Holdings

$1,824.49

12.59 (0.69%)

FB

Facebook

$156.16

2.6 (1.69%)

SNAP

Snap

$7.23

-0.18 (-2.43%)

VFC

VF Corp.

$88.01

0.36 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 28

    Oct

  • 30

    Oct

  • 31

    Oct

  • 05

    Nov

  • 07

    Nov

  • 08

    Nov

  • 13

    Nov

  • 15

    Nov

PF

Pinnacle Foods

$66.43

0.2 (0.30%)

, AMRX

Amneal Pharmaceuticals

$18.05

-0.68 (-3.63%)

10:23
10/16/18
10/16
10:23
10/16/18
10:23
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

PF

Pinnacle Foods

$66.43

0.2 (0.30%)

AMRX

Amneal Pharmaceuticals

$18.05

-0.68 (-3.63%)

SCCO

Southern Copper

$41.72

-0.42 (-1.00%)

SNN

Smith & Nephew

$34.42

0.28 (0.82%)

SPRO

Spero Therapeutics

$8.19

-1.64 (-16.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 07

    Nov

  • 28

    Feb

SYMC

Symantec

$19.92

0.14 (0.71%)

, LVS

Las Vegas Sands

$56.55

0.71 (1.27%)

10:23
10/16/18
10/16
10:23
10/16/18
10:23
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…

SYMC

Symantec

$19.92

0.14 (0.71%)

LVS

Las Vegas Sands

$56.55

0.71 (1.27%)

CGNX

Cognex

$46.21

2.11 (4.78%)

TPR

Tapestry

$43.55

0.46 (1.07%)

CBRL

Cracker Barrel

$156.00

2.86 (1.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

  • 19

    Nov

  • 06

    Dec

JNJ

Johnson & Johnson

$137.42

3.67 (2.74%)

, SYK

Stryker

$172.58

3.16 (1.87%)

10:22
10/16/18
10/16
10:22
10/16/18
10:22
Recommendations
Johnson & Johnson, Stryker, Zimmer Biomet, Globus Medical, NuVasive, SeaSpine, Cooper Companies, Insulet, TNDM analyst commentary  »

Piper Jaffray discusses…

JNJ

Johnson & Johnson

$137.42

3.67 (2.74%)

SYK

Stryker

$172.58

3.16 (1.87%)

ZBH

Zimmer Biomet

$124.31

0.72 (0.58%)

GMED

Globus Medical

$52.54

0.57 (1.10%)

NUVA

NuVasive

$66.97

1.36 (2.07%)

SPNE

SeaSpine

$15.96

-0.03 (-0.19%)

COO

Cooper Companies

$254.67

1.63 (0.64%)

PODD

Insulet

$90.55

1.64 (1.84%)

TNDM

TNDM

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 19

    Oct

  • 25

    Oct

  • 26

    Oct

  • 28

    Oct

  • 30

    Oct

  • 01

    Nov

  • 27

    Nov

TVTY

Tivity Health

$32.62

0.39 (1.21%)

10:22
10/16/18
10/16
10:22
10/16/18
10:22
Hot Stocks
Tivity says SilverSneakers coming to North Carolina, California MA members »

Tivity Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 27

    Nov

QCOM

Qualcomm

$65.29

1.11 (1.73%)

10:20
10/16/18
10/16
10:20
10/16/18
10:20
Options
Aggressive call buying in Qualcomm »

Aggressive call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

10:20
10/16/18
10/16
10:20
10/16/18
10:20
General news
U.S. JOLTS report showed job openings rose 59k to 7,136k in August »

U.S. JOLTS report showed…

10:20
10/16/18
10/16
10:20
10/16/18
10:20
General news
Treasury Action: yields rebounded from lows »

Treasury Action: yields…

TROX

Tronox

$11.91

0.05 (0.42%)

10:20
10/16/18
10/16
10:20
10/16/18
10:20
Conference/Events
UBS basic materials analyst to hold an analyst/industry conference call »

Analyst Roberts discuss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 06

    Nov

GS

Goldman Sachs

$218.11

2.83 (1.31%)

10:19
10/16/18
10/16
10:19
10/16/18
10:19
Hot Stocks
Breaking Hot Stocks news story on Goldman Sachs »

Goldman expects to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.